Opioid antinociception, tolerance and dependence: Interactions with the N-methyl-D-aspartate system in mice

Linda A. Dykstra, Bradford D. Fischer, Rebecca E. Balter, Fredrick E. Henry, Karl T. Schmidt, Laurence L. Miller

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

This study explored the involvement of N-methyl-D-aspartate (NMDA) in the effects of μ-opioid agonists. A hot-plate procedure was used to assess antinociception and tolerance in mice in which the NR1 subunit of the NMDA receptor was reduced [knockdown (KD)] to approximately 10%, and in mice treated with the NMDA antagonist, (-)-6-phosphonomethyl-deca-hydroisoquinoline-3- carboxylic acid (LY235959). The μ opioid agonists, morphine, l-methadone and fentanyl, were approximately three-fold less potent in the NR1 KD mice than in wild-type (WT) controls; however, the development of morphine tolerance and dependence did not differ markedly in the NR1 KD and the WT mice. Acute administration of the NMDA antagonist, LY235959, produced dose-dependent, leftward shifts in the morphine dose-effect curve in the WT mice, but not in the NR1 KD mice. Chronic administration of LY235959 during the morphine tolerance regimen did not attenuate the development of tolerance in the NR1 KD or the WT mice. These results indicate that the NR1 subunit of the NMDA receptor does not play a prominent role in μ opioid tolerance.

Original languageEnglish (US)
Pages (from-to)540-547
Number of pages8
JournalBehavioural Pharmacology
Volume22
Issue number5-6
DOIs
StatePublished - Sep 2011
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Opioid antinociception, tolerance and dependence: Interactions with the N-methyl-D-aspartate system in mice'. Together they form a unique fingerprint.

Cite this